The Brazilian Health Regulatory Agency, Agência … relapsed high-risk neuroblastoma in Brazil. It’s very exciting to … creating access to DANYELZA in Brazil from the joint efforts by … Y-mAbs. MSK has institutional financial interests related to the compound …
Y-mAbs’ DANYELZA approved in Brazil for the treatment of high-risk neuroblastoma
26.05.2023
Без рубрики